Background and Purpose-The critical access hospital (CAH) designation was established to provide rural residents with local access to emergency and inpatient care. CAHs, however, have poorer short-term outcomes for pneumonia, heart failure, and myocardial infarction compared with other hospitals. We assessed whether 30-day risk-standardized mortality rates (RSMRs) and risk-standardized readmission rates (RSRRs) after ischemic stroke differ between CAHs and non-CAHs. Methods-The study included all fee-for-service Medicare beneficiaries 65 years of age or older with a primary discharge diagnosis of ischemic stroke (International Classification of Diseases, 9th revision codes 433, 434, 436) in 2006.
T he critical access hospital (CAH) designation was established as part of the Medicare Rural Hospital Flexibility Program in the 1997 Balanced Budget Act to support the financial viability of small rural hospitals and to provide rural residents local access to emergency and inpatient care. 1 CAHs were defined as being Ͼ35 miles from the nearest hospital (Ͼ15 miles in mountainous terrain or areas with only secondary roads), having Ͻ25 inpatient beds (Ͻ15 beds if not a swing bed facility), averaging a length of stay Յ96 hours, and providing 24-hour emergency care services 7 days per week.
The number of CAHs has increased since the program's inception from 41 hospitals in January 1999 to 1327 hospitals as of March 2011. CAH conversion has contributed to the financial viability of many rural hospitals, [2] [3] [4] and it has had a positive effect on some patient safety 2 and quality-of-care metrics. 1 Despite these improvements, CAHs lag behind non-CAHs on many performance measures and have poorer short-term outcomes for pneumonia, heart failure, and myocardial infarction. 1, 5 Information about outcomes for stroke patients treated at CAHs is limited. Assessing stroke outcomes is important to ensure optimal quality of care in rural areas, because community awareness of stroke, adherence to evidence-based guidelines for stroke treatment, and deficiencies in specialists, diagnostic technologies, and acute stroke teams may influence care in these settings. 6 -11 To assess the impact of CAH status on stroke outcomes, we determined 30-day hospital-level risk-standardized mortality rates (RSMRs) and risk-standardized readmission rates (RSRRs) for ischemic stroke discharges from all United States hospitals in 2006.
Materials and Methods

Study Sample
The study population included all Medicare fee-for-service beneficiaries 65 years of age or older hospitalized with a primary discharge diagnosis of ischemic stroke (International Classification of Diseases, 9th revision, Clinical Modification codes 433, 434, and 436) from January 1 to December 31, 2006. Data were obtained from the Medicare Provider Analysis and Review files and included demographic information, primary and secondary discharge diagnosis codes, and procedure codes for each hospitalization. We included patients with 12 months of continuous Medicare fee-for-service enrollment before and 1 month after the hospitalization to obtain complete medical history, mortality, and readmission information. Patients who were younger than 65 years were not included in the analysis because they do not represent typical Medicare patients. Patients discharged from nonacute care facilities, transferred to or from another acute care facility, discharged within 1 day of admission, or who left the hospital against medical advice were also excluded. Hospitals were classified according to their CAH status in 2006. 12 
Outcomes
Outcome measures were hospital-level 30-day all-cause RSMR and 30-day all-cause RSRR. Mortality information was obtained from the Medicare Enrollment Database and was assessed from the date of hospital admission. The accuracy of vital status is high for this age group using these data resources. 42 Readmissions included those for any cause to an acute care hospital treating Medicare patients within 30 days of discharge. We excluded readmissions to any acute care hospital for procedures that may represent planned continuation of treatment after discharge from the index stroke admission, unless International Classification of Diseases, 9th revision, Clinical Modification 433.x1 or 434.x1 (reflecting an acute stroke) was listed as the principal discharge diagnosis for the hospital readmission. Reasons for planned readmissions were determined a priori and included carotid endarterectomy, carotid stenting, percutaneous carotid or vertebral artery stenting, intracranial stenting, patent foramen ovale closure, cardiac ablation procedures, aortic or mitral valve replacement, and cranioplasty.
Patient and Hospital Characteristics
Preexisting comorbidities were identified using the primary and 9 secondary codes from claims submitted in the year before the index hospitalization and from claims from the index admission for conditions that would not represent an acute stroke complication (eg, hypertension or diabetes) to adjust for differences in case mix that would not reflect stroke-related quality of care. Potentially preventable complications of acute stroke (eg, pneumonia or urinary tract infection) that could reflect quality of care and may impact 30-day mortality or readmissions were excluded from the adjustment. Because there are Ͼ15 000 International Classification of Diseases, 9th revision, Clinical Modification codes, these codes are grouped into clinically coherent categories using the Hierarchical Condition Categories, a system developed by physician and statistical consultants under a contract to the Centers for Medicare and Medicaid Services. A total of 29 independent variables were included from inpatient administrative claims data, including 2 demographic variables (age and sex), 7 cardiovascular and stroke history variables (congestive heart failure, acute myocardial infarction, unstable angina, chronic atherosclerosis, cardiopulmonary-respiratory failure, peripheral vascular disease, cerebrovascular disease), and 20 other variables that identify additional coexisting illnesses (eg, hypertension, chronic obstructive pulmonary disease, renal failure, liver disease, dementia, cancer). These variables have been used in the calculation of RSMRs and RSRRs for previous studies examining hospital-level outcomes after ischemic stroke. 14 
Statistical Analysis
Patient characteristics and outcomes were compared between CAHs and non-CAHs by using 2 tests for categorical variables and Wilcoxon rank-sum tests for continuous variables and by calculating the standardized difference between the 2 hospital groups. 15, 16 Consistent with methods described in the development of administrative models, [17] [18] [19] [20] a hierarchical generalized linear model that includes patient-level and hospital-level data was used to relate the log-odds of 30-day mortality to patient risk factors for the study cohort. The model provided data to compute standardized hospitalspecific estimates as well as quantitative summaries of betweenhospital variation after adjusting for case mix. An RSMR was calculated for each hospital using the regression coefficients from the hierarchical generalized linear model. A linear regression model in conjunction with the Markov chain Monte Carlo simulation method was then used to compare RSMRs of CAHs with non-CAHs at the hospital-level. This model used RSMRs as an outcome with CAHs as the referent category and assessed whether the posterior probability of RSMRs is different between non-CAH volume categories (Ͻ25th, 25th-50th, 50th-75th, and Ͼ75th percentiles) and CAHs. The posterior probability was estimated based on the proportion of total times that a coefficient of each volume-specific dummy variable was Ͼ0 (ie, higher RSMR than CAH) from 10 000 Markov chain Monte Carlo simulations. The same analytic methods were used to compare RSRRs between CAHs and non-CAHs. All analyses were conducted using SAS 9.2 (SAS Institute, Cary, NC). Statistical testing was 2-sided at a significance level of ␣ϭ0.05, with hierarchical models estimated using the GLIMMIX procedure.
Results
There were 310 381 ischemic stroke discharges in 2006: 10 267 from 1165 CAHs and 300 114 from the 3381 nonCAHs (Table 1) . Patients treated at CAHs were older, more often white, and more frequently had a history of dementia and functional disability. They were less likely to have a history of chronic atherosclerosis, respiratory failure, previous cerebrovascular disease, renal failure, or peripheral vascular disease. CAHs had higher unadjusted in-hospital mortality rates (6.4% vs 4.6%), a shorter mean length of stay (4.0 vs 4.6 days), and a higher percentage of patients discharged to skilled nursing or intermediate care facilities (26.9% vs 20.7%) than non-CAHs. CAHs had a smaller median bed size, treated fewer stroke patients annually, and were less likely to be Joint Commission-certified primary stroke centers or teaching hospitals than non-CAHs ( Table 2 ). The differences persisted, although they were less marked, for comparisons between CAHs and low-volume non-CAHs. Mean Medicare payments per hospitalization tended to be higher in the higher-volume hospitals, but the differences were not substantial (Figure 1) .
Patients hospitalized at CAHs had higher 30-day mortality rates than those at non-CAHs (19.9% vs 10.9%; PϽ0.001) but lower 30-day all-cause readmission rates (12.4% vs 13.8%; PϽ0.001). The hospital-level RSMRs were higher for 
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CAHs than non-CAHs (11.9%Ϯ1.4% vs 10.9%Ϯ1.7%; PϽ0.001), with no difference in 30-day readmissions (13.7%Ϯ0.6% vs 13.7%Ϯ1.4%; Pϭ0.3; Figure 2 ). Compared with CAHs, the RSMRs for non-CAHs decreased with increased hospital volume quartile, but there was no difference for RSRRs (Figures 3 and 4) .
Discussion
Overall, CAHs had higher mean 30-day RSMRs compared with non-CAHs, but there was no difference in 30-day RSRRs. Higher-volume non-CAHs had lower RSMRs than CAHs, but low-volume non-CAHs had RSMRs that were similar to CAHs. There was no difference for RSRRs by CAH status or hospital volume quartile. The Rural Hospital Flexibility Program Tracking Team found that CAHs are involved in a range of quality-related activities (eg, continuing education, error reporting policies, error prevention, data collection), and that their involvement in these programs remained stable or strengthened after receiving CAH designation. 2, 21, 22 Factors thought to enhance quality of care in CAHs include increased staffing, network- ing with larger acute care hospitals, improvements in case management and discharge planning, and revision of patient safety processes. 2, 21, 22 Despite these improvements, CAHs continue to lag behind non-CAHs in resources, clinical capabilities, provision of care consistent with quality metrics, and outcomes. 1, 5 Studies comparing CAHs with non-CAHs find higher short-term mortality for several conditions. 1, 5 We extend these analyses by showing higher short-term mortality for ischemic stroke at CAHs, but no difference in RSRRs by CAH status. We also noted heterogeneity in RSMRs by hospital volume, with CAHs having RSMRs comparable with non-CAHs of similar size.
Data comparing readmission rates for CAHs and nonCAHs are limited. A previous study using Medicare data from rural and urban hospitals in Iowa, Maine, North Dakota, Oregon, and Utah found that unadjusted readmission rates for rural hospitals were higher than for urban hospitals; however, these differences were attenuated after adjusting for patient age. 23 The rates were higher for urban hospitals compared with rural hospitals after adjustment for disease severity. We found no differences in 30-day readmission rates in riskstandardized hospital-level comparisons.
Several factors may contribute to higher mortality rates for stroke patients treated at CAHs. By definition, CAHs serve rural populations with limited access to emergency care. Given their rural locales, patients cared for at CAHs likely live at greater distances from any hospital, including larger hospitals with more specialized services. With potentially longer travel times, rural patients may arrive at CAHs in worse condition. 24, 25 The relative lack of available and readily mobilized emergency medical services also may contribute to longer presentation and transport delays. 24, 25 The economic and geographic constraints of CAHs themselves may contribute to acute care treatment delays. 25, 26 We also found that mean payments to CAHs for stroke patients were lower than those to non-CAHs, especially in comparison with largervolume hospitals, although the differences were small.
Patients treated at CAHs differ systematically from those treated at non-CAHs. Rural residents tend to be older, uninsured, and have more limited access to primary care services. 24, [27] [28] [29] [30] They also tend to have a higher prevalence of stroke risk factors, yet they have less knowledge regarding the warning signs and risk factors for stroke. The CAHs often serve as triage centers for stroke patients and transfer patterns may reflect patient characteristics. For example, 1 study found that patients with acute myocardial infarction who remained in community hospitals were older and sicker than those transferring to other facilities. 31 Several studies report that rural patients who are younger are more likely to be transferred to urban hospitals than older patients. [32] [33] [34] [35] [36] [37] [38] Patients may also prefer to be treated at local CAHs and refuse transfer to distant, larger, better-equipped, and better-staffed medical centers. 29, 30 Higher case volume is generally associated with better care and outcomes. 39 -41 The low volume of stroke cases treated at CAHs may not be sufficient for the staff to maintain adequate clinical skills. Rural hospitals have limited availability of specialty caregivers, diagnostic technologies, and acute stroke care teams. 6 -10 Rural-urban gaps also have been noted in adherence to evidence-based guidelines for stroke treatment, 6 ,11 although compliance with secondary stroke preventive therapies is similar. 42 We found that there was no difference in stroke mortality between CAHs and similarly sized non-CAHs, suggesting that lower volume rather than CAH status per se may explain much of the difference.
Our study has limitations. Although the positive predictive values for the selected ischemic stroke International Classification of Diseases, 9th revision, Clinical Modification codes are relatively high, the index ischemic stroke cases were not verified by record review. 43, 44 We were able to adjust for differences in case mix based on comorbid conditions, but Medicare inpatient data do not contain information on stroke severity, which can be an important predictor of outcomes. 45 Data were not available to assess stroke process of care measures, but a previous study found that CAHs had lower performance on these types of measures for other conditions, including acute myocardial infarction, congestive heart failure, and pneumonia, even after adjusting for case mix and other hospital characteristics. 5 The study lacked data on the experience of caregivers treating stroke patients, decisionmaking about the receipt of care, time from symptom onset to 
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hospital presentation, and other aspects of outpatient care that my affect outcomes. Although Medicare fee-for-service beneficiaries aged 65 years and older represent the majority of ischemic stroke events, the results may not be applicable to those without fee-for-service Medicare coverage or to stroke patients younger than age 65 years. We analyzed outcomes for a single year and did not assess whether patterns have changed since the inception of the CAH program. Finally, our study examined short-term mortality and readmissions and did not consider other important dimensions of patient outcomes such as functional status or quality of life. Because at least a portion of the difference in stroke mortality rates between CAHs and non-CAHs may be explained by lower volume, procedures such as the adoption of standardized care maps and conduct of "mock stroke codes" may be helpful. The provision of telemedicine services to rural hospitals also extends stroke care expertise to underserved facilities. Additional work is needed to determine the effectiveness of these types of interventions. 6 
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